Literature DB >> 18181390

Control of rheumatic heart disease in the Pacific region.

Andrew Steer1, Samantha Colquhoun, Sara Noonan, Joseph Kado, Satupaitea Viale, Jonathan Carapetis.   

Abstract

This article outlines the impact of rheumatic heart disease for the individual, the international community and the Pacific region. It then appraises the three main strategies for control of rheumatic heart disease. Secondary prevention is the regular delivery of antibiotic prophylaxis to prevent further episodes of recurrent rheumatic fever and is the only prevention activity that is proven to be effective and cost effective at the individual and community level. The article explores the essential facets of a successful control program focussing upon health education and promotion, and then discusses previous experience with control programs for rheumatic heart disease. Finally it describes the current Pacific Rheumatic Heart Disease Control Program.

Entities:  

Mesh:

Year:  2006        PMID: 18181390

Source DB:  PubMed          Journal:  Pac Health Dialog        ISSN: 1015-7867


  4 in total

1.  Acute rheumatic fever in First Nations communities in northwestern Ontario: Social determinants of health "bite the heart".

Authors:  Janet Gordon; Mike Kirlew; Yoko Schreiber; Raphael Saginur; Natalie Bocking; Brittany Blakelock; Michelle Haavaldsrud; Christine Kennedy; Terri Farrell; Lloyd Douglas; Len Kelly
Journal:  Can Fam Physician       Date:  2015-10       Impact factor: 3.275

2.  Health-related quality of life of patients after mechanical valve replacement surgery for rheumatic heart disease in a developing country.

Authors:  Linda J Thomson Mangnall; David W Sibbritt; Margaret Fry; Melanie Windus; Robyn D Gallagher
Journal:  Heart Asia       Date:  2014-12-09

3.  Low adherence to secondary prophylaxis among clients diagnosed with rheumatic fever, Jamaica.

Authors:  Sheron Boswell Thompson; Cerese Hepburn Brown; Ann Marie Edwards; Jascinth L M Lindo
Journal:  Pathog Glob Health       Date:  2014-08-11       Impact factor: 2.894

Review 4.  Cutting edge issues in rheumatic fever.

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.